These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 33757294)

  • 21. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
    Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
    Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of miR-142-3p improves mitochondrial function in cardiac hypertrophy.
    Liu BL; Cheng M; Hu S; Wang S; Wang L; Tu X; Huang CX; Jiang H; Wu G
    Biomed Pharmacother; 2018 Dec; 108():1347-1356. PubMed ID: 30372837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice.
    Song C; Qi H; Liu Y; Chen Y; Shi P; Zhang S; Ren J; Wang L; Cao Y; Sun H
    Mol Ther; 2021 Mar; 29(3):1120-1137. PubMed ID: 33130312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A long noncoding RNA protects the heart from pathological hypertrophy.
    Han P; Li W; Lin CH; Yang J; Shang C; Nuernberg ST; Jin KK; Xu W; Lin CY; Lin CJ; Xiong Y; Chien H; Zhou B; Ashley E; Bernstein D; Chen PS; Chen HV; Quertermous T; Chang CP
    Nature; 2014 Oct; 514(7520):102-106. PubMed ID: 25119045
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myocardial Hypertrophic Preconditioning Attenuates Cardiomyocyte Hypertrophy and Slows Progression to Heart Failure Through Upregulation of S100A8/A9.
    Wei X; Wu B; Zhao J; Zeng Z; Xuan W; Cao S; Huang X; Asakura M; Xu D; Bin J; Kitakaze M; Liao Y
    Circulation; 2015 Apr; 131(17):1506-17; discussion 1517. PubMed ID: 25820336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sphingosine-1-phosphate ameliorates the cardiac hypertrophic response through inhibiting the activity of histone deacetylase-2.
    Yan H; Yi S; Zhuang H; Wu L; Wang DW; Jiang J
    Int J Mol Med; 2018 Mar; 41(3):1704-1714. PubMed ID: 29286094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.
    Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED
    Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cardiac hypertrophy is positively regulated by long non-coding RNA PVT1.
    Yu YH; Hu ZY; Li MH; Li B; Wang ZM; Chen SL
    Int J Clin Exp Pathol; 2015; 8(3):2582-9. PubMed ID: 26045764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lysosomal cysteine peptidase cathepsin L protects against cardiac hypertrophy through blocking AKT/GSK3beta signaling.
    Tang Q; Cai J; Shen D; Bian Z; Yan L; Wang YX; Lan J; Zhuang GQ; Ma WZ; Wang W
    J Mol Med (Berl); 2009 Mar; 87(3):249-60. PubMed ID: 19096818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. KS370G, a synthetic caffeamide derivative, improves left ventricular hypertrophy and function in pressure-overload mice heart.
    Weng YC; Chuang CF; Chuang ST; Chiu HL; Kuo YH; Su MJ
    Eur J Pharmacol; 2012 Jun; 684(1-3):108-15. PubMed ID: 22484506
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long non-coding RNA cytoskeleton regulator RNA (CYTOR) modulates pathological cardiac hypertrophy through miR-155-mediated IKKi signaling.
    Yuan Y; Wang J; Chen Q; Wu Q; Deng W; Zhou H; Shen D
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1421-1427. PubMed ID: 30794866
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exercise preconditioning attenuates pressure overload-induced pathological cardiac hypertrophy.
    Xu T; Tang H; Zhang B; Cai C; Liu X; Han Q; Zou L
    Int J Clin Exp Pathol; 2015; 8(1):530-40. PubMed ID: 25755743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. OBG-like ATPase 1 inhibition attenuates angiotensin II-induced hypertrophic response in human ventricular myocytes via GSK-3beta/beta-catenin signalling.
    Narasimhan G; Henderson J; Luong HT; Rajasekaran NS; Qin G; Zhang J; Krishnamurthy P
    Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):743-751. PubMed ID: 31063653
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antagonizing the CX3CR1 Receptor Markedly Reduces Development of Cardiac Hypertrophy After Transverse Aortic Constriction in Mice.
    Nemska S; Gassmann M; Bang ML; Frossard N; Tavakoli R
    J Cardiovasc Pharmacol; 2021 Dec; 78(6):792-801. PubMed ID: 34882111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure.
    Li XM; Ma YT; Yang YN; Liu F; Chen BD; Han W; Zhang JF; Gao XM
    Clin Exp Pharmacol Physiol; 2009 Nov; 36(11):1054-61. PubMed ID: 19566828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA Chast promotes cardiac remodeling.
    Viereck J; Kumarswamy R; Foinquinos A; Xiao K; Avramopoulos P; Kunz M; Dittrich M; Maetzig T; Zimmer K; Remke J; Just A; Fendrich J; Scherf K; Bolesani E; Schambach A; Weidemann F; Zweigerdt R; de Windt LJ; Engelhardt S; Dandekar T; Batkai S; Thum T
    Sci Transl Med; 2016 Feb; 8(326):326ra22. PubMed ID: 26888430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial Leptin Receptor Deletion Promotes Cardiac Autophagy and Angiogenesis Following Pressure Overload by Suppressing Akt/mTOR Signaling.
    Gogiraju R; Hubert A; Fahrer J; Straub BK; Brandt M; Wenzel P; Münzel T; Konstantinides S; Hasenfuss G; Schäfer K
    Circ Heart Fail; 2019 Jan; 12(1):e005622. PubMed ID: 30621510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart failure with preserved ejection fraction: chronic low-intensity interval exercise training preserves myocardial O2 balance and diastolic function.
    Marshall KD; Muller BN; Krenz M; Hanft LM; McDonald KS; Dellsperger KC; Emter CA
    J Appl Physiol (1985); 2013 Jan; 114(1):131-47. PubMed ID: 23104696
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1β upregulation via nuclear factor κB activation.
    Higashikuni Y; Tanaka K; Kato M; Nureki O; Hirata Y; Nagai R; Komuro I; Sata M
    J Am Heart Assoc; 2013 Nov; 2(6):e000267. PubMed ID: 24249711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A gene therapeutic approach to inhibit calcium and integrin binding protein 1 ameliorates maladaptive remodelling in pressure overload.
    Grund A; Szaroszyk M; Döppner JK; Malek Mohammadi M; Kattih B; Korf-Klingebiel M; Gigina A; Scherr M; Kensah G; Jara-Avaca M; Gruh I; Martin U; Wollert KC; Gohla A; Katus HA; Müller OJ; Bauersachs J; Heineke J
    Cardiovasc Res; 2019 Jan; 115(1):71-82. PubMed ID: 29931050
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.